Awards for July 2013

Federal Awards

July Awards

Adinoff, Bryon, NIH, Striatal Dopamine Release in Response to Ultraviolet Light in Compulsive Tanners, $169,931; Alto, Neal, NIH, Type III Effector Regulation of Host GTPase Signaling, $357,993; Bai, Xiaoying, NIH, Role of Transcriptional Intermediary Factor TIF1g in Vertebrate Hematopoiesis, $244,707; Barth, Bradley, Univ. of Iowa/NIH, Inspire to Study Acute Recurrent and Chronic Pancreatitis in Children, $5,670; Beutler, Bruce, Scripps Research Inst./NIH, Discovery and Analysis of Synthetic TLR Agonists and Antagonists, $11,481.

Bezprozvanny, Ilya, NIH, Calcium Channels as Novel Therapeutic Targets for Huntington’s Disease, $335,639; Brown, Kathlynn, NIH, Multilayered Valency: Novel Design of Peptidic Imaging Agents for alpha v beta6, $337,358; Bruick, Richard, NIH, Study of Iron-Responsive E3 Ligase Regulating Mammalian Iron Homeostasis, $16,165; Burgess, Shawn, Duke Univ./NIH, Development of Novel Therapies for NIDDM: Project 3, $332,310; Byerly, Matthew, Columbia Univ./NIH, 2/2: Comparison of Long-Acting Injectable Medication for Schizophrenia (ACLAIMS), $6,840.

Casey, Brian, George Washington Univ./NIH, Eunice Kennedy Schriver NICHD-MEFU Clinical Ctr. Agreement-Capitation Payments, $256,821; Castrillon, Diego, NIH, Mouse Models and Translational Studies of Endometrial Cancer – Diversity Supplement, $16,918; Chalak, Lina Fahd, NIH, Cerebrovascular Dysfunction in Newborns with HIE During Hypothermia and Rewarming, $123,309; Chen, David, UC Berkeley/NIH, Structural Cell Biology of DNA Repair Machines, $73,242; Chiang, Cheng-Ming, NIH, E2-Cellular Complexes in HPV Chromatin Transcription, $98,977.

Cleaver, Ondine, NIH, Blood Vessel Tubulogenesis: Rasip1-Directed GTPase Signaling and Cell Polarity, $20,670; Deberardinis, Ralph, NIH, Metabolic Regulators of Tumor Cell Growth, $232,597; Delgado-Ayala, Mauricio, UT Arlington/NIH, Near Infrared Brain Imaging for Guiding Treatment in Children with Cerebral Palsy, $58,670; Dowling, Michael, UC San Francisco/NIH, Vascular Effects of Infection in Pediatric Stroke: VIPS, $21,168; Dowling, Michael, Univ. of Colorado/NIH, Investigation of Prognostic Factors in Childhood-Onset AIS: Role of Stroke Subtype, $4,250.

Drazner, Mark, Duke Univ./NIH, STICHES – Surgical Treatment of Ischemic Heart Failure, $450; Friedman, Deborah, Univ. of Rochester/NIH, Data Coordination and Biostatistics Center for NORDIC Network, $51,001; Friedman, Deborah, Thomas Jefferson Univ./NIH, Diagnosing and Managing the Headache Patient – Staying Ahead of Headache Pain, $5,000; Galindo, Rene, NIH, Minority Predoctoral NLHBI Research Training at UT Southwestern, $6,155; Gao, Jinming, NIH, Ultra-Responsive "ON/OFF" Fluorescent Nanoprobes for Cancer Molecular Imaging, $345,915.

Drazner, Mark, Duke Univ./NIH, STICHES – Surgical Treatment of Ischemic Heart Failure, $450; Friedman, Deborah, Univ. of Rochester/NIH, Data Coordination and Biostatistics Center for NORDIC Network, $51,001; Friedman, Deborah, Thomas Jefferson Univ./NIH, Diagnosing and Managing the Headache Patient – Staying Ahead of Headache Pain, $5,000; Galindo, Rene, NIH, Minority Predoctoral NLHBI Research Training at UT Southwestern, $6,155; Gao, Jinming, NIH, Ultra-Responsive "ON/OFF" Fluorescent Nanoprobes for Cancer Molecular Imaging, $345,915.

Ghose, Subroto, NIH, Synaptic Plasticity in Adolescent Cannabis Users: Relevance to Schizophrenia, $444,472; Gill, Michelle, Univ. of Wisconsin/NIH, Inner-City Asthma Consortium (ICAC): Asthma Phenotypes in Inner-City (APIC) Mechanistic Study, $497,739; Gill, Michelle, NIH, Effect of Atopy on Dendritic Cell Antiviral Responses, $373,509; Goldberg, Mark, NIH, Network of Excellence in Neuroscience Clinical Trials (NEXT), $261,156; Green, Carla, NIH, Structure/Function Studies of Mammalian Circadian Clock Proteins, $306,870; Green, Carla, Univ. of Virginia/NIH, Analysis of New Circadian Mutant, $71,550.

Grishin, Nick, NIH, Computational Methods for Structural-Functional Studies of Proteins, $296,207; Gupta, Olga, Univ. of Massachusetts/NIH, Impact of Pet Ownership on Blycemic Control in Youth with Type 1 Diabetes, $26,879; Hendrixson, David, NIH, Campylobacter Jejuni Flagellar Regulation and Synthesis, $373,650; Hibbs, Ryan, NIH, 3-D Structure and Function of Neuronal Nicotinic Acetylcholine Receptors, $240,252; Hilgemann, Donald, NIH, Cardiac Function and PIP2, $19,619.

Hobbs, Helen, NIH, Role of PNPLA3 in Fatty Liver Disease, $352,901; Hsia, Connie, NIH, Nanoparticle Drug Delivery in Post-Pneumonectomy Compensatory Lung Growth, $35,374; Hsieh, Jenny, NIH, Epigenetic Regulation of Adult Neurogenesis, $289,425; Hsieh, Jer-Tsong, NIH, Targeting Aggressive Prostate Cancer with Novel Theranostic NanoMED, $305,137; Huang, Guo, NIH, Retinoic Acid Signaling in Heart Development and Regeneration, $124,554.

Huang, Hao, NIH, Structural Development of Human Fetal Brain, $344,479; Huang, Jun-Shen, NIH, JAK2 Signaling in Erythropoiesis, $378,420; Huber, Kimberly (C. Hale, Fellow), NIH, Mechanisms of MEF2-Dependent Synapse Elimination, $29,420; Igarashi, Peter, NIH, Regulation of Kidney-Specific Gene Expression, $333,722; Igarashi, Peter, NIH, Renal Control of Body Composition and Blood Pressure (MPI), $239,440.

Jiang, Jin, NIH, Complex Regulation of Ci-Gli Proteins in Hedgehog Signal Transduction, $22,220; Jimenez, Patricia T., Washington Univ. in St. Louis/NIH, Reproductive Scientist Development Program, $135,000; Johnson, Mark D, Yale Univ./NIH, Insulin Resistance Intervention after Stroke (IRIS) Trial, $1,158; Knudsen, Erik, NIH, Action of RB Pathway in Breast Cancer Therapy, $300,826; Kohler, Jennifer (N. Pham, Fellow), NIH, Sialic Acid Has Putative Signaling Roles in Muscle Disorders of Aging, $29,829.

Le, Lu Quang, NIH, Roles of Tumor Microenvironment in Neurofibroma Development and Therapeutics, $161,664; Leitch, Ann Marilyn, Natl. Surgical Adjuvant Breast & Bowel/NIH, STAR P-2 Trial Service Agreement, $2,000; Lenkinski, Robert E., NIH, PARACEST Agents: Optimization for Human MR Imaging, $37,767; Levine, Benjamin David, NASA, Effects of Microgravity on Intracranial Pressure, $304,500; Levine, Beth, NIH, Beclin 1-Bcl-2 Interactions: Effects on Autophagy, $290,255; Levine, Beth, UT Medical Branch/NIH, Autophagy-Inducing Peptide as Novel Therapeutic for Intracellular NIAID Class A, B, and C Priority Pathogens, $142,349.

Liu, Yi, NIH, Mechanism and Functions of Small RNA Pathways in Neurospora - Diversity Supplement, $52,907; Lu, Hanzhang, NIH, Normalized Functional MRI in Human Brain Disorders, $477,242; Lu, Hanzhang, NIH, Modulation of Brain Activity by Control of Inspired Air, $333,307; Malloy, Craig Riggs, Duke Univ./NIH, Development of Novel Therapies for NIDDM: Project 4, $444,403; Malter, James Samuel, Univ. of Wisconsin/NIH, Role of Eosinophils in Airway Inflammation and Remodeling, $356,325.

Mammen, Pradeep P, NIH, Cytoglobin: Stress-Responsive Hemoprotein Modulating Cardiomyocyte Survival, $20,670; Marrero, Jorge Alberto, Univ. of Michigan/NIH, Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach, $19,336; Mason, Ralph Peter, Baylor Coll. of Medicine/NIH, Chemotherapeutic Agents with Enhanced Selectivity for Tumor Microenvironment, $28,440; Mendelson, Carole R., NIH, Mechanisms in the Regulation of SP-A Gene Expression, $24,345; Meyer, Dan M., Natl. Science Fndtn., Novel Wireless Power Transmission Architecture for Devices Implanted in Human Bodies, $42,760.

Miller, David Scott, Gynecologic Oncology Group/NIH, Gynecologic Oncology Group Studies (Per Capita), $7,815; Miller, Richard Tyler, NIH, Biophysical Properties of Renal Glomeruli and Podocytes, $528,287; Mineo, Chieko, NIH, Discovery of Novel Interventions of Antiphospholipid Syndrome, $378,420; Mohan, Chandra, NIH, Lupus Genes and B-Cell Signaling, $16,786; Morrison, Sean Joseph, NIH, Regulation of Stem Cell Aging, $282,235.

Munshi, Nikhil V., NIH, Molecular Dissection of Cardiac Conduction System Development, $130,040; Nedzi, Lucien A., American Coll. of Radiology/NIH, Radiation Therapy Oncology Group (RTOG); Agreement No. 5915, $11,900; Nesbitt, Shawna D., Minneapolis Med. Research Fndtn./NIH, ASPirin in Reducing Events in Elderly (ASPREE), $12,480; Olson, Daiwai, Advanced Circulatory Systems Inc./NIH, Physiological Effects of Intrathoracic Pressure Regulation in Patients with Decreased Cerebral Perfusion Due to Brain Injury or Intracranial Pathology, $32,119; Olson, Eric N., NIH, Deciphering Regulatory Circuit for Myocardial Metabolism and Energy Homeostasis, $28,858.

Orth, Kim A., NIH, Analysis of Newly Identified Adhesin Used by Pathogenic Gram-Negative Bacteria, $224,190; Otwinowski, Zbyszek, Argonne Natl. Laboratory/U.S. Department of Defense, Midwest Center for Structural Genomics Protein Structure Initiative: Biology, $22,114; Pandita, Tej Krishan, NIH, Tumor-Cell-Specific Targets for Combined Hyperthermia and Radiation Effects, $300,826; Parada, Luis Fernando, NIH, Neurofibromatosis Research Center: From Animal Models to Therapeutics, $1,244,799; Pasare, Chandrashekhar, NIH, Toll-Like Receptor Mediated Regulation of Effector and Memory CD4 T Cell Responses, $369,914.

Pascual, Juan M, NIH, Modulation of Neural Function in Energy Failure, $335,639; Patel, Vishal D., NIH, miRNA-Based Therapeutics in Polycystic Kidney Disease, $79,500; Paulk, Mary Elizabeth, Dana-Farber Cancer Inst./NIH, Black-White Differences in Advanced Cancer Communication, Acceptance, and Care, $49,214; Pedrosa, Ivan, NIH, Non-Invasive Physiologic Predictors of Aggressiveness in Renal Cell Carcinoma, $278,574; Perez-Fontan, Julio, NIH, National Children’s Study Centers - Lamar County, $208,305.

Pfeiffer, Julie K, NIH, Enteric Virus-Microbiota Interactions, $395,511; Phelan, Herbert, Univ. of Pittsburgh/U.S. Department of Defense, PreHOSP Air Medical Plasma (PAMPer) Trial, $206,042; Phillips, Margaret Anna, NIH, Targeting S-Adenosylmethionine Decarboxylase for HAT Drug Discovery, $802,730; Phillips, Margaret Anna, NIH, Polyamine and Trypanothione Metabolism in Trypanosoma Brucei, $360,282; Rohatgi, Anand Kumar, NIH, Moving Beyond HDL Cholesterol, HDL Function as a Coronary Disease Biomarker, $117,720.

Roth, Michael Gordon, NIH, Lung Cancer Oncogenotype-Selective Drug Target Discovery (MPI), $175,584; Sadek, Hesham A., NIH, Role of Meis1 in Regulation of Cardiomyocyte Proliferation, $378,420; Sanchez, Pablo J., RTI Internatl/NIH, NICHD Neonatal Research Network Capitation Funding, $10,053; Satterthwaite, Anne Bristol, NIH, Inhibitory Receptors in Early B Cell Development, $186,825; Schaffer, Joseph I., NIH, NICHD Pelvic Floor Disorders Network Clinical Sites, $95,740; Schaffer, Joseph I., RTI International/NIH, NICHD Pelvic Floor Disorders Network - Capitation Funding, $1,560.

Scherer, Philipp E., NIH, Novel Mechanisms Regulating Adipocyte-Brain-Hepatocyte Axis, $1,430,469; Scherer, Philipp E., NIH, White Adipose Tissue Physiology, Mitochondrial Function and Adiponectin, $464,280; Scherer, Philipp E., NIH, Endocrine and Metabolism Training Grant, $231,548; Schiller, Joan, Eastern Coop Oncology Group/NIH, ECOG Clinical Trials - Federal Payments, $86,050; Self, David W., McLean Hosp./NIH, Role and Regulation of Class IIA HDACs in Cocaine Addiction, $9,074.

Sherry, Dean, Duke Univ./NIH, Development of Novel Therapies for NIDDM: Core A, $151,050; Souza, Rhonda Frances, NIH, Role of Acid in Development of Barrett’s Esophagus, $264,459; Spence, Jeffrey S., NIH, Integrating Multimodal Brain Imaging Data to Assess Subtle Cognitive Impairment, $2,989; Sperandio, Vanessa, NIH, Sugar Regulation of EHEC Virulence, $373,650; Takahashi, Joseph S., NIH, Transcriptional Architecture and Chromatin Landscape of Circadian Clocks in Aging Tissue, $278,250.

Tamminga, Carol A., NIH, Psychosis and Affective Research Domains and Intermediate Phenotypes (PARDIP), $237,881; Tamminga, Carol A., Mount Sinai School of Medicine/NIH, Epigenetic Mechanisms of Depression, $152,640; Terada, Lance S., NIH, Training Program in Lung Biology and Disease, $397,287; Toto, Robert Daniel, Univ. of Utah/NIH, Systolic Blood Pressure Intervention Trial (SPRINT) - Capitated, $51,487.

Trivedi, Madhukar Hariprasad, NIH, Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care: EMBARC, $1,927,800; Trivedi, Madhukar Hariprasad, NIH, Mood Disorders Clinical Intervention Training Program, $330,378; Trivedi, Madhukar Hariprasad, NIH, Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care: EMBARC – Administrative Advertising Supplement, $146,229;

Ufret-Vincenty, Rafael, NIH, Role of Complement Factor H and Immunity in AMD: Novel Transgenic Model, $377,625; Van Buren, Peter Noel, NIH, Mechanisms of Increased Ambulatory Blood Pressure in Intradialytic Hypertension, $144,612.

Vusirikala, Madhuri, Natl. Marrow Donor Program/NIH, RDSafe: Multicenter Study of Hematopoietic Stem Cell Donor Safety and Quality of Life, $500; Wang, Serena Xiaohong, Jaeb Ctr. of Health Research/NIH, Pediatric Eye Disease Investigator Group: Amblyopia Treatment Study, $477; Warach, Steven, Massachusetts General Hosp./NIH, MR WITNESS: Phase IIa Study of Intravenous Thrombolysis with Alteplase, $18,177; Washington, Doris Lambracht, NIH, Characterization of Regulatory T Cells Generated in DNA Abeta42 Immunized Mice, $75,128; White, Michael A., NIH, Components of RAS Mediated Growth Control, $228,934.

Wiebe, Deborah J., Univ. of Utah/NIH, Self-Regulation Approach to Diabetes Adherence into Emerging Adulthood, $252,185; Willson, James, NIH, Cancer Center Support Grant, $1,332,377; Wolf, Matthias, Cincinnati Children’s Hosp./NIH, Pediatric Physician Scientist Program Award, $17,325; Wolf, Steven E., Geneva Fndtn./US DOD, Phases of Illness Paradigm (POIP), $38,987; Zhang, Chengcheng, NIH, Role of Inhibitory Receptors in Leukemia Development, $82,481.

Zhang, Hong, NIH, Molecular Interactions of Mammalian Circadian Clock Proteins, $290,890; Zhang, Rong, NIH, Arterial Aging, Brain Perfusion and Exercise: Impact on Brain Structure and Function, $27,047; Zimmern, Philippe E., New England Research Institutes/NIH, UITN Steering Committee, $36,921; Zinn, Andrew R., NIH, Medical Scientist Training Program at UT Sourthwestern, $817,730; Zinn, Andrew R., NIH, Medical Scientist Training Program at UT Southwestern - Graduate Partnership Supplement, $37,170.

Non-Federal Awards

Ahn, Chul, CPRIT, C1: Biostatistics, $120,001; Alto, Neal, Burroughs Wellcome Fund, Systems Architecture of Bacterial Effector/Host Membrane Interactions, $100,000; Attanasio, Massimo, Satellite Healthcare, Role of Hedgehog Signaling in Kidney Apoptosis and Fibrosis, $50,000; Bibb, James, American Cancer Society, Development of New Treatment Strategies for MEN2 Cancer, $240,000; Boothman, David, American Assn. for Cancer Research, NQO1-Mediated “Kiss of Death” Targeted Therapy for Pancreatic Cancer, $100,000.

Brekken, Rolf, American Cancer Society, Fibulin-5 as Regulator of Tumor Angiogenesis, $180,000; Chen, David, CPRIT, P1: Impact of DNA-PKcs Phosphorylation at T2609 Cluster on Pathway Choice for DNA Double-Strand Break Repair and Tumorigenesis - P1 Project, $279,182; Chen, David, CPRIT, AC: DNA Double-Strand Break Repair and Genome Stability, $98,751; Chook, Yuh Min, Leukemia and Lymphoma Society, Mechanisms of CRM1-Mediated Nuclear Export in Leukemia, $110,000.

Choy, Hak, CPRIT, AC: Technology Directed Advances in Radiation Therapy of Lung Cancer, $119,635; Cleaver, Ondine (S. Meadows, Fellow), American Heart Assn. Southwest Affiliate, Elucidating Function of Annexim A3 during Cardiovascular Development, $50,048; Corey, David, ALS Assn., Therapeutic Targeting and Molecular Pathology in c9FTD/ALS, $80,000; Deberardinis, Ralph, Damon Runyon Cancer Research Fndtn., Translational Studies in Cancer Metabolism, $150,000; Elmquist, Joel (J. Sohn, Fellow), American Diabetes Assn., Identification of Central Serotonergic Pathways that Regulate Energy and Glucose Homeostasis, $42,750.

Galindo, Rene (K. Galindo, Fellow),Alex’s Lemonade Stand, Screening for New Rhabdomyosarcama Gene in Drosophila Model, $50,000; Gazdar, Adi,CPRIT, P1: Establishing New Validated Cancer Cell Lines in Vitro, $244,224; Graff, Jonathan (A. Lim, Fellow),American Heart Assn. Southwest Affiliate, Role of Estrogen Receptor Alpha in Adipose Development, $46,796; Graff, Jonathan (R. Ugrankar, Fellow),American Diabetes Assn., Characterization of Novel Genetic Factors of Hyperglycemia Identified in Drosophila Melanogaster through Partial Genome Screen, $45,000.

Greenberg, Benjamin (A. Desena, Fellow), Transverse Myelitis Assn., Neuroimmunology Fellowship, $78,000; Greenberg, David, Emory Univ./Cystic Fibrosis Fndtn., Virulence Determinants for Host Tropism in the Burkholderia Cepacia Complex, $25,963; Gumbo, Tawanda, Univ. of Groningen, Clinical Pharmacology of Ertapenem in Treatment of TB, $30,000; Hedayati, Susan (N. Jain, Fellow), American Heart Assn. Southwest Affiliate, Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study, $70,000; Hill, Joseph, CPRIT, P3: Maladaptive Cardiomyocyte Autophagy as Mechanism of Doxorubicin-Induced Heart Failure, $300,000.

Horton, Jay (S. Rong, Fellow), American Heart Assn. Southwest Affiliate, Phenotyping Characterization of SREBP2 Knockout Mice, $43,976; Huang, Jun-Shen (G. Bulut, Fellow), American Heart Assn. Southwest Affiliate, Role of p85 and c-Cbl in Erthropoietin Receptor Down-Regulation, $25,000; Kim, Taekyung, Esther A. and Joseph Klingenstein Fund, Functional Implication of Novel Class of Noncoding RNAs in Neuronal and Behavioral Plasticity, $50,000; Le, Lu Quang, TexasNeurofibromatosis Fndtn., Therapeutic Opportunities for Malignant Peripheral Nerve Sheath Tumors, $20,000; Le, Lu Quang (A. Patel, Fellow), Children’s Tumor Fndtn., Epigenetic Mechanisms Underlie Malignant Peripheral Nerve Sheath Tumor Development, $32,000.

Lenkinski, Robert E., CPRIT, Recruitment of Missing Links, $364,108; Lu, Qing Richard, Natl. Multiple Sclerosis Society, MicroRNA Control of Myelination and Remyelination in Central Nervous System, $172,904; Marciano, Denise K., Satellite Healthcare, Role of Afadin/Nectin Complexes in Renal Tubulogenesis, $100,000; Marple, Bradley Franklin, American Geriatric Society, UT Southwestern Chief Resident Immersion Training Program, $36,000; Mason, Ralph Peter, CPRIT, C1: In Vivo Imaging Core, $169,877.

McKnight, Steven L., CPRIT, AC: Discovery of New Drugs for Treatment of Lung Cancer, $131,654; Mendell, Joshua T., CPRIT, Recruitment of Rising Stars, $900,000; Minna, John D., CPRIT, P1: Molecular Biomarker ID, $394,751; Mohan, Chandra (S. Pathak, Fellow), Arthritis Fndtn. North Texas Chapter, Novel Gene for Receptor Revision in Mature B-Cells, $50,000; Monson, Nancy Lee, Natl. Multiple Sclerosis Society, Antibody Gene Signature in Transverse Myelitis, $101,984.

Morrison, Sean (B. Zhou, Fellow),Leukemia and Lymphoma Society, Determining Cell-of-Origin of Mouse Leukemias, $55,000; O’Donnell-Mendell, Kathryn Ann,CPRIT, Recruitment of First-Time, Tenure-Track Faculty Members, $500,000; Olson, Eric N.,CPRIT, P2: MicroRNA Mechanisms and Therapies to Protect Heart During Cancer Chemotherapy, $300,000; Pfeiffer, Julie K.,Burroughs Wellcome Fund, How Gut Microbes Enhance Enteric Virus Infectivity, $100,000; Posner, Bruce Arthur,CPRIT, C2: HTS Core, $409,552.

Radhakrishnan, Arun, American Heart Assn. Natl. Ctr., Cholesterol Sensing in Cell Membranes, $77,000; Ready, Joseph Martin, CPRIT, P3: Chemistry, $399,772; Repa, Joyce, American Diabetes Assn., Vitamin D Receptor and Islet Biology, $103,500; Rhee, Chanhaeng, UT System, Reducing Avoidable Harm from Device-Related Health Care-Associated Infection (HAI), $165,000; Rohatgi, Anand Kumar, American Heart Assn. Natl. Ctr., Moving Beyond HDL Cholesterol, HDL Function as Coronary Disease Biomarker, $77,000.

Rosenbaum, Daniel Mark, Searle Scholars Program, Mechanisms of Integral Membrane Signaling Proteins Involved in Human Disease, $100,000; Sadek, Hesham A., American Heart Assn. Southwest Affiliate, Regulation of Adult Heart Regeneration by miR-15 Family, $70,000; Schneider, Jay W., CPRIT, P5: Coronary Microvasculature as Target for Cardioprotection for Cancer-Therapy Induced Heart Failure, $262,527; Schneider, Jay W., CPRIT, Administrative Core: Cardiotoxicity of Cancer Chemotherapy: Novel Mechanisms and Therapeutic Strategies, $78,168; Schroit, Alan Jay, CPRIT, P2: Analysis of Determinants of Anti-Tumor Activity of Engineered Antibodies and Antibody Fusions in Mouse Models, $326,901.

Sherry, Dean, American Diabetes Assn., In Vivo Quantification of Beta Cell Function with MRI Using Zinc Responsive Contrast Agent, $49,999; Sherry, Dean (J. Anderson, Fellow), American Diabetes Assn., In Vivo Imaging of Beta Cell Function with Zinc Responsive Contrast, $45,000; Sun, Xiankai, CPRIT, Acquisition of Biomedical Cyclotron and Development of Comprehensive Positron Emission Tomography Program at UT Southwestern for Cancer Research, $300,000; Timmerman, Robert, CPRIT, P1: Realizing Technological Advances; State of Texas Advanced Radiation Therapy (START) Trials, $686,603; Umetani, Michihisa, American Diabetes Assn., Modulation of Adiposity 27-Hydroxycholesterol, the First Identified Endogenous SERM, $138,000.

Van Buren, Peter Noel,American Heart Assn. Natl. Ctr., Mechanisms of Increased Ambulatory Blood Pressure in Intradialytic Hypertension, $132,000; Ward Ober, Elizabeth Sally,CPRIT, P1: Engineering Antibodies and Antibody Fusion Proteins that Target PS to Produce New Generation Therapeutics, $317,128; Ward Ober, Elizabeth Sally,CPRIT, AC: Engineering Anti-Phosphatidylserine Antibodies for Cancer Therapy, $100,862; White, Michael A.,CPRIT, P2: Compound Target ID; Discovery of New Drugs for Treatment of Lung Cancer, $569,082; White, Michael A.,CPRIT, P3: Mapping Landscape of Conditional Vulnerabilities in Ovarian Cancer, $279,183.

Williams, Noelle S., CPRIT, C3: Pharmacology Core, $235,983; Xing, Chao, American Heart Assn. Natl. Ctr., Identifying Less Frequent Variants with Large Effect Sizes in Genome-Wide Scans, $77,000; Yu, Hongtao, CPRIT, P3: Regulation of DNA Repair Pathway Choice by Cohesin and Smc5/6 Complex, $279,184; Yu, Yonghao, CPRIT, Recruitment of First-Time, Tenure-Track Faculty Members, $250,000..

Industry Sponsored Awards, dollar amounts not available

Abu-Hijleh, Muhanned, IBV Valave System for the Treatment of Prolonged Air Leak; Abu-Hijleh, Muhanned, Study of Tiotropium Bromide Delivered via HandiHaler in Chronic Obstructive Pulmonary Disease (COPD) Subjects Recovering from Hospitalization for Acute Exacerbation (Hospital Discharge Study 2); Bartolome, Sonja, Phase 3b Study of Riociguat in Patients with Inoperable CTEPH, or Recurrent or Persisting Ph Post PEA; Beg, Muhammad, STEAM (Sequencing Triplet with Avastin and Maintenance); Chopra, Rajiv, Philips Pivotal Clinical Trial for MRI-guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids.

Collins, Robert, Ph3 Study of Ponatinib; Frankel, Arthur, Therapy Targeting the Interleukin-3 Receptor (IL3R) for Patients with Relapsed or Refractory and Elderly Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) with DT388IL3 (SL-401) (IND# 11314): Phase IB Clinical Trial; Gerber, David, Ph2 Trial of Oral Intermittent Dacomitinib in Patients with Advanced NSCLC; Guleserian, Kristine, EXCOR Pediatric VAD Post Approval Study; Iannaccone, Susan, Study of Single Intrathecal Dose of ISIS 396443 in Patients with Spinal Muscular Atrophy Who Previously Participated in ISIS 396443- CS1.

Karp, David, Ph3 Study of BMS-188667 (Abatacept) or Placebo in Subjects with Active Class III or IV Lupus Nephritis; Kershaw, Corey, Extension Trial of Oral BIBF 1120 in Patients with Idiopathic Pulmonary Fibrosis (PIF); Lotan, Yair, Cxbladder® Urine Test for Detection of Recurrent Urinary Tract Urothelial Carcinoma (UC); Lotan, Yair, Evaluation of Xpert® Bladder Assay for Detection and Monitoring of Recurrence for Bladder Cancer; McCavit, Timothy, NovaFerrum vs. Ferrous Sulfate in Treatment of Nutritional Iron Deficiency Anemia.

McCulley, James, Study Coordinator Agreement; Miller, David, Study Comparing AEZS-108 with Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer; Miller, David, Ph2 Study of VTX-2337 with Pegylated Liposomal Doxorubicin in Patients with Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer; Rahimi, Assal, Pilot Study of HylaCareTM for Acute Skin Changes in Patients Undergoing External Beam Radiotherapy for Breast Tumors; Raskin, Philip, Ph3 Study of ITCA 650 to Sitagliptin as Add-on Therapy to Metformin in Patients with Type 2 Diabetes.

Reimold, Andreas, Certolizumab Pegol plus Methotrexate Compared with Adalimumab plus Methotrexate in Sujects with Moderate to Severe Rheumatoid Arthritis; Rohatgi, Anand, Assessment of Cholesteryl Ester Transfer Protein Inhibition with Evacetrapib in Patients at High Risk for Vascular Outcomes: ACCELERATE Study; Schiller, Joan, Ph3 Study of Ganetespib with Docetaxel vs Docetaxel Alone in Patients with Advanced Non-Small-Cell Lung Cancer; Singal, Amit, Ph3 Study of Tivantinib (Arq197) in Subjects with MET Diagnostic-High Inoperable Hepatocellular Carcinoma (HCC).

Share: